US precision immune-oncology firm I-Mab has entered into a definitive agreement to acquire 100% ownership of Bridge Health ...

The Institute for Clinical and Economic Review (ICER) has cast doubt on the value of a new spinal muscular atrophy treatment ...

Behind the Numbers 2026 report, outlining the primary inflators and deflators of healthcare costs across the industry. It ...

Japanese drug major Astellas Pharma has signed a memorandum of understanding with the Korea Institute of Startup and ...

French ophthalmology company Nicox (EPA: ALCOX) has signed an agreement with Japan’s Kowa Company (TYO: 7807).

A major collaboration between the Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative is set to ...

The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable ...

French biotech One Biosciences has raised 15 million euros ($16 million) in series A financing to advance development of its ...

The Bristol Myers Squibb-Pfizer Alliance today announced a new direct-to-patient option for purchasing Eliquis (apixaban) via ...

South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...

US companies SandboxAQ and iOncologi have announced a strategic collaboration to jointly develop, validate, and commercialize ...

Spanish plasma-derived medicines specialist Grifols saw its share close up 7% yesterday, after it revealed that it will ...